article thumbnail

Introducing the Borderline Personality Disorder Inventory

Psychiatric Times

Knoll IV, MD November 19th 2024 4 Ways to Cope With Bipolar Uncertainty James Phelps, MD September 19th 2024 Borderline Personality Disorder and Complex Posttraumatic Stress Disorder: Myths in Diagnosis Mark L.

article thumbnail

Intergenerational Gaps and the Role of Technology in Psychiatric Leadership: A Trainee’s Perspective

Psychiatric Times

Technology offers benefits like enhanced education but poses challenges such as reduced human connection and ethical concerns. Effective psychiatric leadership requires balancing generational and technological dynamics to foster collaboration and innovation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Psychiatric Pipeline in Review: Quarter 2, 2025

Psychiatric Times

Trontinemab showed significant amyloid plaque reduction in Alzheimer's, validating Brainshuttle technology and prompting a phase 3 study. Additionally, Vanda initiated a phase 3 clinical study for Bysanti as a once-daily adjunctive treatment for major depressive disorder in the fourth quarter of 2024. Results are expected in 2026.

article thumbnail

sNDA Submitted: Lumateperone for the Prevention of Relapse in Schizophrenia

Psychiatric Times

An sNDA for Caplyta as an adjunctive treatment for adults with major depressive disorder (MDD) is also currently under FDA review, submitted back in December 2024. December 3, 2024. The most commonly reported adverse events were somnolence/sedation, dizziness, nausea, and dry mouth. points (effect size 0.61) in study 501 and 4.5

article thumbnail

TSND-201 Receives Breakthrough Therapy Designation From FDA for PTSD

Psychiatric Times

August 8, 2024. Transcend Therapeutics Announces Primary Endpoint Met in IMPACT-1 Phase 2 Study of TSND-201 in PTSD. Press release. March 31, 2025. Officials, V eterans Urge Careful Consideration for MDMA-Assisted Psychotherapy. Psychiatric Times. Accessed July 10, 2025.

article thumbnail

Behind the Smiles: Mental Health in South Korea’s High-Pressure Society

Mad in America

S outh Korea is often celebrated for its remarkable economic growth, technological advancement, and cultural exports like K-pop and Korean dramas. The Numbers Behind the Crisis In a 2024 national survey , 73.6% Most outpatient psychiatric visits last less than 10 minutes. Psychotherapy is rarely suggested.

article thumbnail

PTSD Is Treatable, But There's No Holy Grail: Insights From Arash Javanbakht, MD

Psychiatric Times

August 9, 2024. September 11, 2024. but in what areas can we improve treatment outcomes and real-world functioning for patients with PTSD? but in what areas can we improve treatment outcomes and real-world functioning for patients with PTSD? References 1. 5 key take-aways about PTSD treatment: a closer look at MDMA. Psychiatric Times.